We do more than make pharmaceutical cannabis products.
We make them accessible.
Panaxia is transforming pharmaceutical cannabis with consistent, effective, high-quality products that can be used the same way as other medicines. Many chronic patients don’t or can’t use medical cannabis in the form it’s most commonly taken (via smoking or vaping). At Panaxia, we offer products with the unique properties of cannabinoids in forms that these patients are familiar and comfortable with – tablets, suppositories and the like.
ABOUT US
It’s not just the cannabinoids that make our products effective.
It’s also the science.
The power of our approach is to bring science and pharma standards to the still-evolving world of medical cannabis. Our substantial investment in research and development include a large internal R&D team and clinical partnerships with prominent medical centers. The result of our well-established scientific approach - Products physicians feel confident recommending. And patients feel comfortable taking.
R&D & Tech
Bringing pharmaceutical standards to medical cannabis.
We are the first company to be granted a license by the Israeli Ministry of Health to make pharmaceutical cannabis products under the stringent Good Manufacturing Practice (GMP) guidelines. This certification ensures that our products are manufactured under the most demanding requirements for validation and standardization, so both patients and physicians alike can count on their consistency – no matter where they’re made.
Our Products
Trusted collaboration with highly experienced strategic partners.
When you’re revolutionizing an entire industry, it helps to have extraordinary strategic partners. Our network is extensive and ever growing, and it operates around the globe. Collaborating with the world’s best medical cannabis companies and organizations enables us to quickly penetrate markets as they develop to bring pharmaceutical-grade cannabis products of the highest quality to as many people as we can
Strategic Partners
Previous
Next

Latest News